IL17A and cancer: The findings depicted in Figure 2C,D and Figure S2F,G indicate that the upregulated genes exhibited significant enrichment in various pathways, including but not limited to the metabolic pathway, pathways in cancer, HIF-1 signaling pathway, IL-17 signaling pathway, NF-Kappa B signaling pathway, and MAPK signaling pathway.